caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1992758155

Anil AsgaonkarMD

NephrologyCorinth, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
649
Unique beneficiaries
—
Total services
1,325
Distinct HCPCS
7
Medicare payment
$93K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 883 Nephrology providers in TX — above median (cohort median 1,432).
REFERRAL NETWORK

Where Anil Asgaonkar's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 40 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
TEXAS HEALTH PRESBYTERIAN HOSPITAL DENTON91715
Gururaj Krishnamurthy
Nephrology · Corinth, TX
651,636
COLUMBIA MEDICAL CENTER OF DENTON SUBSIDIARY LP61414
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
54174
David Suominen
Diagnostic Radiology · Plano, TX
50342
Ryomin Kim
Diagnostic Radiology · Plano, TX
49361
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
44123
Glenn Genovese
Pulmonary Disease · Longview, TX
281,048
Jason Ma
Diagnostic Radiology · Plano, TX
28225
SPECTRA LABORATORIES INC2797
Raul Ortega
Vascular Surgery · Denton, TX
24444
CORINTH INVESTOR HOLDINGS, LLC23100
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
628
Beneficiaries
—
Total drug cost
$19K
Distinct drugs
18
Brand share
1.8%
Top prescribed drugs
Allopurinol91 claims
Bumetanide91 claims
Torsemide91 claims
Potassium Chloride37 claims
Labetalol Hcl37 claims
QUALITY · MIPS · 2024
Final MIPS score
20.4
Quality
0.0
Cost
68.2
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-6.55%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.